RDTCF (Rapid Dose Therapeutics) Inventory-to-Revenue : 0.34 (As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Rapid Dose Therapeutics's Average Total Inventories for the quarter that ended in Nov. 2024 was $0.12 Mil. Rapid Dose Therapeutics's Revenue for the three months ended in Nov. 2024 was $0.36 Mil. Rapid Dose Therapeutics's Inventory-to-Revenue for the quarter that ended in Nov. 2024 was 0.34.

Rapid Dose Therapeutics's Inventory-to-Revenue for the quarter that ended in Nov. 2024 increased from Aug. 2024 (0.33) to Aug. 2024 (0.34)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Rapid Dose Therapeutics's Days Inventory for the three months ended in Nov. 2024 was 67.61.

Inventory Turnover measures how fast the company turns over its inventory within a year. Rapid Dose Therapeutics's Inventory Turnover for the quarter that ended in Nov. 2024 was 1.35.

Rapid Dose Therapeutics Inventory-to-Revenue Historical Data

The historical data trend for Rapid Dose Therapeutics's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Inventory-to-Revenue Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Inventory-to-Revenue

Get a 7-Day Free Trial

1.73

0.35

0.16

0.28

0.14

Rapid Dose Therapeutics Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Inventory-to-Revenue	Get a 7-Day Free Trial															0.58	0.69	0.36	0.33	0.34

Competitive Comparison of Rapid Dose Therapeutics's Inventory-to-Revenue

For the Biotechnology subindustry, Rapid Dose Therapeutics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Inventory-to-Revenue falls into.

Save Embed

;

Save Embed

;

Rapid Dose Therapeutics Inventory-to-Revenue Calculation

Rapid Dose Therapeutics's Inventory-to-Revenue for the fiscal year that ended in Feb. 2024 is calculated as

	Inventory-to-Revenue (A: Feb. 2024 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Feb. 2023 )	+	Total Inventories (A: Feb. 2024 ))	/	count )	/	Revenue (A: Feb. 2024 )
=	( (0.108	+	0.098)	/	2 )	/	0.756
=	0.103					/	0.756
=	0.14

Rapid Dose Therapeutics's Inventory-to-Revenue for the quarter that ended in Nov. 2024 is calculated as

	Inventory-to-Revenue (Q: Nov. 2024 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Aug. 2024 )	+	Total Inventories (Q: Nov. 2024 ))	/	count )	/	Revenue (Q: Nov. 2024 )
=	( (0.138	+	0.108)	/	2 )	/	0.359
=	0.123					/	0.359
=	0.34

Rapid Dose Therapeutics (OTCPK:RDTCF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Rapid Dose Therapeutics's Days Inventory for the three months ended in Nov. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Nov. 2024 )	/	Cost of Goods Sold (Q: Nov. 2024 )	*	Days in Period
	=	0.123	/	0.166	*	365 / 4
	=	67.61

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Rapid Dose Therapeutics's Inventory Turnover for the quarter that ended in Nov. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Nov. 2024 )	/	Average Total Inventories (Q: Nov. 2024 )
	=	0.166	/	0.123
	=	1.35

Rapid Dose Therapeutics Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.